Comments on the article: 'Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation'- Response to Pan et al.
Yi-Fei ChengYuhong ChenChenhua YanYu WangYao ChenWei HanLanping XuXiaohui ZhangKaiyan LiuXiaojun HuangPublished in: British journal of haematology (2018)
Keyphrases
- stem cell transplantation
- high dose
- liver failure
- low dose
- acute lymphoblastic leukemia
- acute myeloid leukemia
- respiratory failure
- multiple myeloma
- diffuse large b cell lymphoma
- cancer therapy
- peripheral blood
- hodgkin lymphoma
- disease activity
- drug induced
- aortic dissection
- drug delivery
- systemic lupus erythematosus
- intensive care unit
- bone marrow
- acute respiratory distress syndrome